Companies
AMD Charges Past Previous Peaks as Chipmaker Hits Fresh All-Time High
Fueled by booming AI demand and marquee partnerships, AMD surges to record levels amid semiconductor market fervour Shares of AMD...
Bitcoin Slides Toward $100,000 as Market Volatility Tests Investor Confidence
Despite global trade tensions and shifting narratives, analysts say long-term signals still support optimism for bitcoin Bitcoin is rapidly approaching...
Praxis Announces Breakthrough Phase 3 Results for Ulixacaltamide in Essential Tremor Treatment
Positive data from Essential3 program marks major step toward first targeted therapy for millions living with essential tremor Praxis Precision...
United Airlines Soars on Customer Loyalty and Strategic Investments as Profits Outpace Expectations
Airline’s $1 Billion Customer Experience Strategy Pays Off With Record Q3 Performance and Optimistic Q4 Outlook United Airlines (UAL) delivered...
Genprex Shares Gain as Positive Preclinical Lung Cancer Data to Be Presented at Global Oncology Conference
REQORSA® gene therapy shows promise against hard-to-treat ALK-positive non-small cell lung cancer Clinical-stage gene therapy developer Genprex (GNPX) announced that...
Australian Oilseeds Holdings Surges on Strong Export Demand and Rising Global Vegetable Oil Prices
Renewed interest in renewable fuels and Asian trade momentum boost investor confidence Shares of Australian Oilseeds Holdings (COOT) moved sharply...
Wall Street’s Biggest Analyst Calls Today: Upgrades Favor Tech, Downgrades Hit Industrials and Healthcare
Semiconductor optimism drives bullish calls on AMD and Monolithic Power while managed care stocks come under pressure Wall Street analysts...
U.S. Rare Earth Stocks Surge as Trade Tensions With China Escalate
MP Materials and USA Rare Earth rally more than 20% amid fresh export restrictions and tariff threats U.S. rare earth...
OpenAI Doubles Down on Custom AI Chips in Landmark Broadcom Partnership
Deal to co-develop 10 GW of accelerators signals aggressive hardware strategy amid AI arms race OpenAI has entered a major...
J&J Eyes Biotech Buyout to Strengthen Immunology Pipeline
Prospective acquisition of Protagonist Therapeutics centers on oral drug for immune diseases Johnson & Johnson (JNJ) is reportedly in active...
